Latest News

Date Title Topic
29 Sep 2014 ESMO 2014: Cobimetinib in Combination with Vemurafenib Improves PFS in BRAF-Mutant Unresectable Locally-Advanced or Metastatic Melanoma Personalised medicine - Melanoma - Anticancer agents & Biologic therapy
29 Sep 2014 ESMO 2014: Combination Dabrafenib/Trametinib Improves OS in Comparison with Vemurafenib in Patients With BRAF-Mutation Positive Melanoma Personalised medicine - Melanoma - Anticancer agents & Biologic therapy
29 Sep 2014 ESMO 2014: Results of a Phase III Randomised Study of Nivolumab in Patients with Advanced Melanoma After Prior Anti-CTLA4 Therapy Melanoma - Immuno-oncology
29 Sep 2014 European Medicines Agency Recommends Granting a Marketing Authorisation for Nintedanib Lung and other thoracic tumours - Anticancer agents & Biologic therapy
29 Sep 2014 ESMO 2014 Press Release: PIK3CA Mutations Blunt Benefit of Anti-HER2 Drugs Breast cancer - Translational research - Anticancer agents & Biologic therapy
29 Sep 2014 ESMO 2014: Results From the CALGB/SWOG 80405 and FIRE-3 (AIO KRK-0306) Studies In All RAS Wild Type Population Gastrointestinal cancers - Anticancer agents & Biologic therapy
29 Sep 2014 Liquid biopsies: Tumour diagnosis and treatment monitoring in a blood test Translational research - Basic science
29 Sep 2014 ESMO 2014 Press Release: RAS Testing Only the First Step for Choosing Treatment for Metastatic Colorectal Cancer, Important New Data Show Gastrointestinal cancers
29 Sep 2014 ESMO 2014: Targeted Treatments for Subsets of NSCLC Patients With Folate-Receptor-Positive, BRAF V600E-Mutant, and With Tumours Carrying HER2 Somatic Mutations Lung and other thoracic tumours - Anticancer agents & Biologic therapy
29 Sep 2014 Pathway of the Day: CDK Pathology/Molecular biology
29 Sep 2014 ESMO 2014 Press Commentary: Anti-PD-L1 Antibody Shows Promising Activity in Advanced Bladder Cancer after Decades of Silence Genitourinary cancers - Immuno-oncology
29 Sep 2014 ESMO 2014 Press Release: Promising Results Shown with Targeted Approaches in Subsets of Non-Small-Cell Lung Cancer Lung and other thoracic tumours
29 Sep 2014 ESMO 2014 Press Release: New Data on Combination Treatments for Melanoma Melanoma
29 Sep 2014 ESMO 2014 Press Release: Nivolumab Shows Signs of Superior Response Rate Compared to Standard Chemotherapy in Advanced Melanoma Melanoma - Immuno-oncology
29 Sep 2014 ESMO 2014 Press Release: Studies Report New Findings on Treatment Options for Mesothelioma Lung and other thoracic tumours - Immuno-oncology - Anticancer agents & Biologic therapy